Summit Investment Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,021
| Closed | -$250K | – | 56 |
|
|
2025
Q1 | $250K | Sell |
12,021
-3,230
| -21% | -$67.1K | 0.12% | 60 |
|
|
2024
Q4 | $359K | Sell |
15,251
-1,025
| -6% | -$24.1K | 0.19% | 45 |
|
|
2024
Q3 | $417K | Buy |
+16,276
| New | +$417K | 0.22% | 42 |
|
|
2024
Q2 | – | Sell |
-18,859
| Closed | -$542K | – | 42 |
|
|
2024
Q1 | $542K | Sell |
18,859
-561
| -3% | -$16.1K | 0.32% | 36 |
|
|
2023
Q4 | $637K | Buy |
19,420
+55
| +0.3% | +$1.81K | 0.4% | 31 |
|
|
2023
Q3 | $540K | Buy |
19,365
+42
| +0.2% | +$1.17K | 0.4% | 28 |
|
|
2023
Q2 | $659K | Sell |
19,323
-62
| -0.3% | -$2.11K | 0.44% | 28 |
|
|
2023
Q1 | $583K | Buy |
19,385
+109
| +0.6% | +$3.28K | 0.41% | 27 |
|
|
2022
Q4 | $544K | Buy |
+19,276
| New | +$544K | 0.66% | 24 |
|